Vertex Pharmaceuticals (VRTX) Interest Coverage Ratio Growth (1y) (2010 - 2025)
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Interest Coverage Ratio Growth (1y) (2010 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -60.78% |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | -176.09% |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | 93.04% |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | -25.59% |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 1,170.12% |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | -53.46% |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 99.48% |
| 10 | Incyte | 25.57 Bn | 21.03 Bn | 1.57 Bn | 34.31% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -0.27% |
| Sep 30, 2025 | 141.50% |
| Jun 30, 2025 | 187.63% |
| Mar 31, 2025 | 91.69% |
| Dec 31, 2024 | 292.93% |
| Sep 30, 2024 | 56.28% |
| Jun 30, 2024 | -487.40% |
| Dec 31, 2020 | 18.31% |
| Sep 30, 2020 | 610.55% |
| Jun 30, 2020 | 184.50% |
| Mar 31, 2020 | 173.66% |
| Dec 31, 2019 | 467.98% |
| Sep 30, 2019 | -37.96% |
| Jun 30, 2019 | 91.08% |
| Mar 31, 2019 | 143.89% |
| Dec 31, 2012 | -213.40% |
| Sep 30, 2012 | -100.77% |
| Mar 31, 2012 | 267.57% |
| Dec 31, 2011 | 183.09% |
| Sep 30, 2011 | 160.49% |